Authored by Liftstream
In January 2013, Liftstream highlighted 13 people we thought the life sciences industry should be watching during 2013 as they took on unique challenges that we marked out for the year ahead. This January, we look back over the past 12 months to see how these same executives navigated and delivered against the over-arching objectives we mapped out.
To read the full Liftstream reviews please follow the links below
Dr. Flemming Ornskov – CEO – Shire
Mr Pascal Soriot – CEO – AstraZeneca
Mr Richard Gonzalez – CEO – AbbVie
Mr David Mott – General Partner – New Enterprise Associates (NEA)
Dr Dalvir Gill – CEO – TransCelerate
Dr. Michael Pellini – CEO – Foundation Medicine
Dr Jeff Leiden – CEO – Vertex Pharmaceuticals
Dr Karl-Ludwig Kley – CEO – Merck KGaA
Mr Richard Bergstrom – Director General – EFPIA
Dr John Martin – CEO – Gilead Sciences
Dr Francois Nader – CEO – NPS Pharmaceuticals
Liftstream would very much like to hear your thoughts on how you believe these life science leaders performed in 2013. Please leave your comments below, email info@liftstream.com or tweet @liftstream #LSL13for13
Liftstream is an executive search and interim management recruitment company working exclusively within the global life science sector.
